Galapagos NV

Galapagos NV is a biotechnology company that focuses on the discovery and development of small molecule medicines. It primarily aims to address unmet medical needs through innovative drug research and development. The company is significantly involved in inflammatory diseases, aiming to deliver novel treatments for conditions such as rheumatoid arthritis and ulcerative colitis. By leveraging its proprietary target and drug discovery platform, Galapagos NV explores a pipeline of investigational drugs, collaborating with major pharmaceutical companies to enhance its research capabilities. Having its roots in Belgium, the company plays a pivotal role in the European biotech sector. With substantial research facilities spread across Europe, including the Netherlands and France, Galapagos NV contributes extensively to the advancement of medical therapies that offer new hope for patients worldwide.